查詢結果分析
來源資料
相關文獻
- Wide Resection of Recurrent Adrenocortical Carcinoma in a Patient with Concomitant Hepatocellular Carcinoma
- 腎上腺偶見瘤之特徵:奇美醫學中心5年臨床經驗
- 肝癌的成因及危險因子
- 肝癌病患家屬參加教育心理團體成效探討
- N-Acetyltransferase in Healthy Human Liver and Hepatoma Tissues
- Adrenal Cortical Carcinoma with Tumor Thrombus of Inferior Vena Cava and Right Atrium
- Use of Color Ultrasound in Percutaneous Intravascular Ethanol Injection into the Supplying Vessel of a Hepatocellular Carcinoma: Report of a Case
- 小型肝癌併腦部轉移
- Hepatocellular Carcinoma Presenting with Acquired Porphyria: A Case Report and Review of the Literature
- Evaluation of a Simplified Staging System for Prognosis of Hepatocellular Carcinoma
頁籤選單縮合
題名 | Wide Resection of Recurrent Adrenocortical Carcinoma in a Patient with Concomitant Hepatocellular Carcinoma=大規模切除復發之腎上腺皮質癌於同時併發肝癌之病人 |
---|---|
作者 | 翁竹浩; 林文榮; 何蓓茵; 許炯明; 蔡家騏; 劉滄柏; Weng, Chu-hao; Lin, Wun-rong; Ho, Pei-yin; Hsu, Jong-ming; Tsai, Chia-chi; Liu, Tsang-pai; |
期刊 | 臺灣癌症醫學雜誌 |
出版日期 | 20111000 |
卷期 | 27:5 2011.10[民100.10] |
頁次 | 頁216-221 |
分類號 | 415.934 |
語文 | eng |
關鍵詞 | 腎上腺皮質癌; 腎上腺偶見瘤; 肝癌; Adrenocortical carcinoma; Adrenal incidentaloma; Hepatocellular carcinoma; |
中文摘要 | 腎上腺皮質癌為一罕見、預後不佳之惡性腫瘤。其病患年齡分布呈現雙峰狀,其一 位於五歲之前,另一高峰位於三十至四十歲之間。主要治療腎上腺皮質癌的方法包括:手 術治療、藥物治療(mitotane)、以及放射線治療。即使經手術完全切除,腎上腺皮質癌 仍有極高機率復發。在此,我們提出一位病患有復發性肝癌,意外發現7 公分腎上腺偶 見瘤。經過腹腔鏡完全切除左腎上腺皮質癌腫瘤後復發,再次大範圍手術切除局部腫瘤 與其相鄰器官之報告。 |
英文摘要 | Introduction: Adrenocortical carcinoma (ACC) is a rare tumor with a high recurrence rate. Despite complete removal of the tumor, many patients will eventually relapse. Case Report: A 62-year-old man with recurrent hepatocellular carcinoma (HCC) who had undergone transcatheter arterial embolization six times in two consecutive years, was found to have a left adrenal incidentaloma by computed tomography (CT) of the abdomen. A stage III ACC was confirmed after surgical removal. Five months later, he underwent complete resection of recurrent ACC involving multiple adjacent organs. HCC recurrence and possible ACC recurrence were noted six months after the second surgery. The patient received Doxorubicin as systemic therapy for 3 month. Conclusions: Complete resection of locally recurrent disease (ACC) without causing severe morbidity may be feasible. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。